Journal article
Development of novel treatments for hepatitis C.
- Abstract:
-
Hepatitis C virus (HCV) infection is a major and growing global health problem, affecting about 170 million people worldwide, and is a leading cause of liver cirrhosis and hepatocellular carcinoma. Currently, treatment is restricted to interferon alfa and ribavirin, which leads to a successful outcome in only about 50% of individuals. New effective treatments with tolerable side-effect profiles are needed urgently, but development has been hindered by an inability to culture HCV and a scarcit...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Lancet. Infectious diseases
- Volume:
- 9
- Issue:
- 2
- Pages:
- 108-117
- Publication date:
- 2009-02-01
- DOI:
- EISSN:
-
1474-4457
- ISSN:
-
1473-3099
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:20440
- UUID:
-
uuid:88ce328e-0856-4d9c-ae1e-07e123155e1c
- Local pid:
- pubs:20440
- Source identifiers:
-
20440
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2009
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record